{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:46:42Z","timestamp":1791254802882,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.rec.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T22:47:16Z","timestamp":1617835636000},"page":"334-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation"],"prefix":"10.1016","volume":"75","author":[{"given":"Sergio","family":"Raposeiras-Roub\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Abu-Assi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Cesp\u00f3n Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Blanco Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Barreiro Pardal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Dom\u00ednguez-Erquicia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Melendo Viu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Bonanad Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Rossell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"\u00cd\u00f1iguez Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2021.02.003_bib0100","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2006.07.034","article-title":"Death and Disability from Warfarin-Associated Intracranial and Extracranial Hemorrhages","volume":"120","author":"Fang","year":"2007","journal-title":"Am J Med."},{"key":"10.1016\/j.rec.2021.02.003_bib0105","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2021.02.003_bib0110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006212","article-title":"Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation","author":"Shah","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"10.1016\/j.rec.2021.02.003_bib0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jamda.2019.08.033","article-title":"Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation","volume":"21","author":"Raposeiras-Roubin","year":"2020","journal-title":"J Am Med Dir Assoc."},{"key":"10.1016\/j.rec.2021.02.003_bib0120","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jacep.2015.02.019","article-title":"Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation)","volume":"1","author":"Fumagalli","year":"2015","journal-title":"JACC Clin Electrophysiol."},{"key":"10.1016\/j.rec.2021.02.003_bib0125","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1212\/WNL.0000000000000248","article-title":"Long-term survival after ischemic stroke in patients with atrial fibrillation","volume":"82","author":"Fang","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.rec.2021.02.003_bib0130","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.003_bib0135","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.rec.2021.02.003_bib0140","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Subcommittee on Control of Anticoagulation. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.rec.2021.02.003_bib0145","first-page":"804","article-title":"Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial","volume":"38","author":"Valgimigli","year":"2017","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2021.02.003_bib0150","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/STROKEAHA.111.630731","article-title":"Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants","volume":"43","author":"Fang","year":"2012","journal-title":"Stroke."},{"key":"10.1016\/j.rec.2021.02.003_bib0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/STROKEAHA.111.636233","article-title":"Relative survival after transient ischaemic attack: results from the Program of Research Informing Stroke Management (PRISM) study","volume":"43","author":"Gattellari","year":"2012","journal-title":"Stroke."},{"key":"10.1016\/j.rec.2021.02.003_bib0160","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/01.STR.0000158917.59233.b7","article-title":"Incidence and short-term prognosis of transient ischemic attack in a population-based study","volume":"36","author":"Kleindorfer","year":"2005","journal-title":"Stroke."},{"key":"10.1016\/j.rec.2021.02.003_bib0165","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/CIRCULATIONAHA.114.013243","article-title":"Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes","volume":"13","author":"Bekwelem","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.003_bib0170","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jama.2017.21917","article-title":"Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality","volume":"319","author":"Inohara","year":"2018","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2021.02.003_bib0175","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/eurheartj\/ehu463","article-title":"Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial","volume":"36","author":"Held","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2021.02.003_bib0180","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/heartjnl-2016-309901","article-title":"Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation","volume":"103","author":"Bahit","year":"2017","journal-title":"Heart."},{"key":"10.1016\/j.rec.2021.02.003_bib0185","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/bmj.323.7323.1218","article-title":"Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practice","volume":"323","author":"Devereaux","year":"2001","journal-title":"BMJ."},{"key":"10.1016\/j.rec.2021.02.003_bib0190","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/CIRCULATIONAHA.117.031354","article-title":"Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation","volume":"138","author":"O\u2019Brien","year":"2018","journal-title":"Circulation."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585721000670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585721000670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:59:45Z","timestamp":1761821985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585721000670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1885585721000670"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2021.02.003","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}